| Literature DB >> 31894652 |
Sándor B Ötvös1, C Oliver Kappe1,2.
Abstract
Reductions of amides and esters are of critical importance in synthetic chemistry, and there are numerous protocols for executing these transformations employing traditional batch conditions. Notably, strategies based on flow chemistry, especially for amide reductions, are much less explored. Herein, a simple process was developed in which neat borane dimethylsulfide complex (BH3 ⋅DMS) was used to reduce various esters and amides under continuous-flow conditions. Taking advantage of the solvent-free nature of the commercially available borane reagent, high substrate concentrations were realized, allowing outstanding productivity and a significant reduction in E-factors. In addition, with carefully optimized short residence times, the corresponding alcohols and amines were obtained in high selectivity and high yields. The synthetic utility of the inexpensive and easily implemented flow protocol was further corroborated by multigram-scale syntheses of pharmaceutically relevant products. Owing to its beneficial features, including low solvent and reducing agent consumption, high selectivity, simplicity, and inherent scalability, the present process demonstrates fewer environmental concerns than most typical batch reductions using metal hydrides as reducing agents.Entities:
Keywords: amides; boranes; continuous flow; esters; reduction
Year: 2020 PMID: 31894652 PMCID: PMC7187139 DOI: 10.1002/cssc.201903459
Source DB: PubMed Journal: ChemSusChem ISSN: 1864-5631 Impact factor: 8.928
Figure 1Continuous‐flow reactor setup for the BH3⋅DMS‐mediated reductions.
Effects of various reaction parameters on the neat BH3⋅DMS‐mediated ester reduction under continuous‐flow conditions (see Figure 1).[a]
|
| |||||||
|---|---|---|---|---|---|---|---|
|
Entry |
[ |
[°C] |
Flow rate [μL min−1] |
Substr./BH3⋅DMS ratio |
[min] |
Conv.[b] [%] | |
|
|
|
|
P1 |
P2 |
|
|
|
|
1 |
2 |
50 |
250 |
150 |
1:3.0 |
30 |
42 |
|
2 |
2 |
90 |
250 |
150 |
1:3.0 |
30 |
100 |
|
3 |
2 |
90 |
310 |
90 |
1:1.5 |
30 |
97 |
|
4 |
2 |
90 |
330 |
70 |
1:1.1 |
30 |
85 |
|
5 |
2 |
90 |
570 |
230 |
1:2.0 |
15 |
96 |
|
6 |
2 |
90 |
620 |
180 |
1:1.5 |
15 |
92 |
|
7 |
2 |
90 |
450 |
150 |
1:1.7 |
20 |
97 |
|
8 |
2 |
90 |
430 |
170 |
1:2.0 |
20 |
100 |
|
9 |
4 |
90 |
330 |
270 |
1:2.0 |
20 |
100 (99)[c] |
|
10 |
8 (neat) |
90 |
230 |
370 |
1:2.0 |
20 |
100 (99)[c] |
[a] No side product formation, chemoselectivity was 100 % in all reactions. [b] Determined by 1H NMR spectroscopy of the crude product. [c] Yield of isolated product in parentheses.
Substrate scope of the neat BH3⋅DMS‐mediated ester reduction under continuous‐flow conditions (see Figure 1 for the flow setup).[a]
|
Entry |
Substrate |
Product |
[ |
Conv.[b] [%] |
Sel.[b] [%] |
|---|---|---|---|---|---|
|
1[c] |
|
|
4 |
100 (99)[d] |
100 |
|
2[c] |
|
|
4 |
100 |
100 |
|
3[c] |
|
|
4 |
98 |
100 |
|
4[e] |
|
|
2 |
93 |
100 |
|
5[c] |
|
|
4 |
100 (99)[d] |
100 |
|
6[c] |
|
|
4 |
100 |
100 |
|
7[c] |
|
|
4 |
100 |
100 |
|
8[c] |
|
|
4 |
100 |
100 |
|
9[c] |
|
|
4 |
99 |
100 |
|
10[c] |
|
|
4 |
98 |
100 |
|
11[c] |
|
|
4 |
100 (98)[d] |
100 |
|
12[c] |
|
|
4 |
100 |
100 |
|
13[c] |
|
|
4 |
95 |
100 |
|
14[c] |
|
|
4 |
96 |
100 |
|
15[c] |
|
|
4 |
99 |
100 |
|
16[f] |
|
|
1 |
67 |
99[g] |
|
17[h] |
|
|
1 |
94 |
98[g] |
|
18[i] |
|
|
0.6 |
100 |
89[j] |
|
19[k] |
|
|
0.6 |
100 |
100 |
|
20[e] |
|
|
2 |
100 (97)[d] |
100 |
|
21[f] |
|
|
1 |
100 |
100 |
|
22[c] |
|
|
4 |
100 |
100 |
|
23[e] |
|
|
2 |
100 |
100 |
|
24[e] |
|
|
2 |
100 (99)[d] |
100 |
|
25[c] |
|
|
4 |
100 |
100 |
|
26[c] |
|
|
4 |
100 (95)[d] |
100 |
|
27[c] |
|
|
4 |
100 |
100 |
|
28[c] |
|
|
4 |
100 |
100 |
[a] Reaction conditions: substrate in 2‐MeTHF, T=90 °C, t r=20 min. [b] Determined by 1H NMR spectroscopy of the crude product. [c] P1 at 330 μL min−1, P2 at 270 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [d] Yield of isolated product in parentheses. [e] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [f] P1 at 500 μL min−1, P2 at 100 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [g] Minor product: 3‐aminobenzyl alcohol. [h] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:4.0. [i] P1 at 510 μL min−1, P2 at 90 μL min−1, substrate/BH3⋅DMS ratio 1:2.9. [j] Minor product: methyl 4‐(1‐hydroxyethyl)benzoate. [k] P1 at 490 μL min−1, P2 at 110 μL min−1, substrate/BH3⋅DMS ratio 1:3.7.
Reduction of various amides with neat BH3⋅DMS under continuous‐flow conditions (see Figure 1 for the flow setup).[a]
|
Entry |
Substrate |
Product |
[ |
Conv.[c] [%] |
Sel.[c] [%] |
|---|---|---|---|---|---|
|
1[d] |
|
|
1 (2‐MeTHF) |
100 (98)[e] |
100 |
|
2[f] |
|
|
0.6 (THF) |
96 |
100 |
|
3[f] |
|
|
0.6 (THF) |
98 |
100 |
|
4[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
5[d] |
|
|
1 (THF) |
100 |
100 |
|
6[f] |
|
|
0.6 (THF) |
100 |
100 |
|
7[f] |
|
|
0.6 (THF) |
100 (96)[e] |
100 |
|
8[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
9[d] |
|
|
1 (2‐MeTHF) |
100 (96)[e] |
100 |
|
10[f] |
|
|
0.6 (THF) |
100 |
100 |
|
11[g] |
|
|
0.3 (2‐MeTHF) |
100 |
100 |
|
12[g] |
|
|
0.3 (THF) |
100 |
100 |
|
13[h] |
|
|
1 (2‐MeTHF) |
100 (95)[e] |
100 |
|
14[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
15[f] |
|
|
0.6 (THF) |
88 (81)[e] |
100 |
|
16[d] |
|
|
1 (2‐MeTHF) |
98 |
85[i] |
|
17[d] |
|
|
1 (2‐MeTHF) |
100 |
100 |
|
18[f] |
|
|
0.6 (2‐MeTHF) |
100 |
100 |
|
19[f] |
|
|
0.6 (THF) |
100 |
100 |
|
20[f] |
|
|
0.6 (2‐MeTHF) |
98 |
100 |
|
21[f] |
|
|
0.6 (THF) |
84 |
100 |
[a] Reaction conditions: T=90 °C, t r=20 min. [b] Solvent used is shown in parentheses. [c] Determined by 1H NMR spectroscopy of the crude product. [d] P1 at 500 μL min−1, P2 at 100 μL min−1, substrate/BH3⋅DMS ratio 1:2.0. [e] Yield of isolated product. [f] P1 at 530 μL min−1, P2 at 70 μL min−1, substrate/BH3⋅DMS ratio 1:2.2. [g] P1 at 560 μL min−1, P2 at 40 μL min−1, substrate/BH3⋅DMS ratio 1:2.4. [h] P1 at 430 μL min−1, P2 at 170 μL min−1, substrate/BH3⋅DMS ratio 1:4.0. [i] Minor product: benzylamine.
Figure 2Continuous‐flow synthesis of pharmaceutically relevant products. (Substrate feed: 330 μL min−1 for A and 500 μL min−1 for B. Reducing agent feed: 270 μL min−1 for A and 100 μL min−1 for B. See also Figure 1).